• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: VASCUTEK LTD GELSOFT; GELSOFT BIFURCATE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

VASCUTEK LTD GELSOFT; GELSOFT BIFURCATE Back to Search Results
Model Number GELSOFT BIFURCATE
Device Problems Material Puncture/Hole (1504); Material Integrity Problem (2978)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 10/18/2021
Event Type  malfunction  
Manufacturer Narrative
Health effect: clinical code: (b)(4): no clinical signs, symptoms or conditions - no health consequences for the patient.Health effect: impact code: (b)(4): no health consequences or impact - no patient harm or consequence: leak suture during procedure.No significant blood loss or delay to procedure.Medical device problem codes (b)(4): material integrity problem: site reported hole at bifurcation appeared during procedure.(b)(4): material puncture / hole: hole reported near to the bifurcation site of device component code: (b)(4): term not applicable: the gelsoft bifurcate does not contain any additional parts or subassemblies.Type of investigation codes: (b)(4): analysis of production records: a review of the retained manufacturing and quality control records confirmed that this batch was manufactured to the intended specifications.Specific emphasis was directed toward the porosity testing results, which clearly indicate good results in the lower end of the test.(b)(4) communication / interviews.Further information was provided by site - graft did not receive any excessive manipulation prior to/during use.It was reported that the graft was not presoaked in saline or other fluid based solutions prior to use/ for 5 minutes as recommended by the included ifu booklet to improve handling and to make the device less susceptible to leakage.However the clinician did indicate that the graft was briefly primed with saline after it was implanted and prior to blood release through the graft.(b)(4): trend analysis: a review of similar events for gelsoft branded devices provided an occurrence rate of (b)(4) (complaint v sales).No reports of leakage has been received for any of the remaining grafts from this batch.(b)(4): device not accessible for testing - device remains in situ and was not explanted.Investigation findings: (b)(4): no device problem found - no issue was found with the review of batch records that could have resulted in leakage reported.Investigation conclusion (b)(4): no problem detected: no issue was found with manufacture qc or physical testing of batch.(b)(4): unintended use error caused or contributed to event: the device was not pre-soaked as per ifu recommendation prior to use and this may have contributed to the event.As no device will be returned for further investigation as it remains implanted vascutek ltd now considers this complaint closed.Further action is not planned, however, the issue will be tracked and trended as part of the on-going complaints trending and reporting process and if an adverse trend develops action may be taken at that time.
 
Event Description
On (b)(6) 2021 a surgeon in (b)(6) reported that blood leaked from a small hole in the inner side of the left branch of the y shaped bifurcation of the gelsoft bifurcate graft.Bleeding site was repaired using prolene sutures and haemostasis was achieved.The surgeon did not clamp this area during the procedure.The graft was not immersed in saline prior to use, but the graft was primed with saline prior to blood flow release.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GELSOFT
Type of Device
GELSOFT BIFURCATE
Manufacturer (Section D)
VASCUTEK LTD
newmains avenue
inchinnan business park
renfrewshire, PA4 9 RR
UK  PA4 9RR
Manufacturer (Section G)
VASCUTEK LTD
newmains avenue
inchinnan business park
renfrewshire, PA4 9 RR
UK   PA4 9RR
Manufacturer Contact
jason whittle
newmains avenue
inchinnan business park
renfrewshire, PA4 9-RR
UK   PA4 9RR
MDR Report Key12819001
MDR Text Key280825861
Report Number9612515-2021-00024
Device Sequence Number1
Product Code MAL
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P890045/S1
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 11/16/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/16/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/31/2022
Device Model NumberGELSOFT BIFURCATE
Device Catalogue Number631610-J
Device Lot Number21690244
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/20/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured03/21/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-